MetaCap

Cumberland Pharmaceuticals Inc. (CPIX)

NASDAQ: CPIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.84-0.46 (-7.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CPIX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$87.57M
EPS (TTM)
-$0.57
Ex-dividend date
Aug 3, 2026
52-week range
2.00 – 9.28
Day range
5.74 – 6.44
Volume / Avg
118.08K / 114.52K
Beta
—

52-week range

$2.00$9.28

CPIX stock today

On Nov 20, CPIX ended the session at $5.84, shedding $0.46 (7.30%), versus the S&P 500's 3.70% decline. At this level, CPIX sits in the middle of its 52-week range of $2.00 to $9.28: 37.1% below the high, set on Aug 26, 2026 and 192.0% above the low. CPIX is up 46.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 193.5%.

Cumberland Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$0.57), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Cumberland Pharmaceuticals

Company profile

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. A. J. Kazimi MBA
Headquarters
Nashville, TN
Employees
88
IPO year
2009

Financial highlights

Full financials

In fiscal 2025, Cumberland Pharmaceuticals generated $44.5 million in revenue, up 17.6% from fiscal 2024. Cumberland Pharmaceuticals reported a net loss of $2.8 million, compared with a loss of $6.5 million a year earlier. Gross margin was 85.0% (up from 82.6%) and operating margin -6.3%.

Cumberland Pharmaceuticals annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$44.52M$37.87M$39.55M$42.01M$35.99M
Growth+17.57%-4.26%-5.85%+16.75%-3.89%
Net income$-2.84M$-6.48M$-6.28M$-5.57M$-3.51M
EPS (diluted)$-0.19$-0.46$-0.44$-0.38$-0.24

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$-0.06 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$1.50
Ex-dividend date
Aug 3, 2026

CPIX news

All CPIX news

Cumberland Pharmaceuticals peers

Health Care sector
CPIX peer companies
CompanyPrice% ChgMarket capCompare
RTSNRetension Pharmaceuticals Inc.10.51-19.22%$87.57Mvs CPIX
EQEquillium Inc.1.06-5.36%$87.26Mvs CPIX
UPBUpstream Bio Inc.1.59-20.50%$87.15Mvs CPIX
ANIXAnixa Biosciences Inc.2.44-6.15%$84.82Mvs CPIX
NTHINeOnc Technologies Holdings Inc.3.15-9.48%$90.88Mvs CPIX
CATXPerspective Therapeutics Inc.0.7538-3.85%$91.03Mvs CPIX
CLLSCellectis S.A. ADR0.9209-7.89%$92.76Mvs CPIX
OGIOrganigram Global Inc.0.583-7.40%$82.27Mvs CPIX

Indexes, lists and sector

Cumberland Pharmaceuticals stock FAQ

What is Cumberland Pharmaceuticals's stock price today?

CPIX last traded at $5.84 as of Nov 20, 4:00 PM EST, down 7.30% on the day. Prices are delayed at least 15 minutes.

Does Cumberland Pharmaceuticals pay a dividend?

Yes. Cumberland Pharmaceuticals pays $0.00 per share annually. The most recent dividend of $1.50 had an ex-dividend date of Aug 3, 2026.

Who is Cumberland Pharmaceuticals's CEO?

Mr. A. J. Kazimi MBA is the chief executive officer of Cumberland Pharmaceuticals Inc., which has about 88 employees.

What is the CPIX 52-week high?

The 52-week high for CPIX is $9.28 and the 52-week low is $2.00. The stock is currently 37.1% below its high.

Compare CPIX